AST (SGOT) aspartate aminotransferase
Showing 1 - 25 of 2,698
Liver Dysfunction, Sepsis-associated Liver Dysfunction Trial in Nanjing (initial aspartate aminotransferase (AST) to platelet
Recruiting
- Liver Dysfunction
- Sepsis-associated Liver Dysfunction
- initial aspartate aminotransferase (AST) to platelet (PLT) ratio index
-
Nanjing, Jiangsu, ChinaInstitute of General Surgery of Jinling Hospital
Aug 11, 2023
Liver Functions Trial in Riyadh (Aerobic training)
Completed
- Liver Functions
- Aerobic training
-
Riyadh, Saudi ArabiaKing Saud University
Jan 19, 2023
HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)
Not yet recruiting
- HIV Infections
- Cabotegravir Formulation F
- Cabotegravir Formulation G
-
Austin, TexasGSK Investigational Site
Sep 4, 2023
Inflammatory and Anti-Inflammatory Gene Expressions in Liver
Active, not recruiting
- Liver Transplant; Complications
- +3 more
- Molecular Immunology , gene expressions
-
Malatya, Turkeyİnönü University
May 2, 2023
Acute Pancreatitis Trial in Zagazig (diagnostic test, device, drug, combination product, dietary supplement, procedure)
Completed
- Acute Pancreatitis
- serum lipase or amylase
- +15 more
-
Zagazig, EgyptZagazig University Faculty of Human Medicine
Nov 3, 2020
Delayed Onset Muscle Soreness Trial in Ankara (Femoral nerve neurodynamic mobilization, Femoral nerve neurodynamic
Completed
- Delayed Onset Muscle Soreness
- Femoral nerve neurodynamic mobilization
- Femoral nerve placebo neurodynamic mobilization
-
Ankara, Beşevler, TurkeyGazi University
Jan 11, 2023
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
Male Infertility Trial (DLBS5055 200mg, Placebo DLBS5055, Multivitamin (Vitamin C 500mg + Vitamin E 100IU + Beta Carotene
Not yet recruiting
- Male Infertility
- DLBS5055 200mg
- +3 more
- (no location specified)
Oct 19, 2023
HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))
Recruiting
- HIV Infections
- Cabotegravir 200 mg/mL
- +2 more
-
Orlando, Florida
- +3 more
Dec 1, 2022
Non-alcoholic Fatty Liver Disease Trial in Pozzilli (nutraceutical mixture, )
Completed
- Non-alcoholic Fatty Liver Disease
- nutraceutical mixture
- placebo
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Jan 11, 2022
Pattern of Autoimmune Hepatitis in Children In Sohag University
Not yet recruiting
- Autoimmune Hepatitis
- liver biobsy
-
Sohag, EgyptSohag university Hospital
Aug 27, 2023
Non-alcoholic Fatty Liver Disease Trial in Zagazig (Rybelsus Oral Product, Ozempic Injectable Product, Tocopherol and/or Actos)
Recruiting
- Non-alcoholic Fatty Liver Disease
- Rybelsus Oral Product
- +2 more
-
Zagazig, Sharkia, EgyptZagazig University
Apr 1, 2023
Plasma MicroRNA for Prediction of Hepatocellular Carcinoma
Completed
- Hepatitis C
- Blood Sampling
-
Banhā, El- Qalyobia, EgyptBenha university
Jul 5, 2022
Urinary Bladder Cancer Trial in Guangzhou (Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin)
Recruiting
- Urinary Bladder Cancer
- Neoadjuvant Toripalimab in Combination With Gemcitabine and Cisplatin
-
Guangzhou, Guangdong, ChinaZhujiang Hospital
Jan 6, 2023
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and
Active, not recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +2 more
- SARS-CoV-2 and/or MIS-C Exposure
-
Loma Linda, California
- +19 more
Sep 22, 2022
Sleep Apnea, Obstructive, Polycythemia Trial in Madrid (device, drug, other)
Not yet recruiting
- Sleep Apnea, Obstructive
- Polycythemia
- Continuous positive airway pressure
- +2 more
-
Madrid, SpainAldara García-Sanchez
Oct 13, 2023
CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)
Recruiting
- CTCL
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 18, 2023
High Plasma Liver Enzymes After Burn Trial (resistance band)
Not yet recruiting
- High Plasma Liver Enzymes After Burn
- resistance band
- (no location specified)
Sep 28, 2023
Inflammatory Response, Metabolic Disturbance Trial (Group fructose, Group Sucrose, Group Glucose)
Completed
- Inflammatory Response
- Metabolic Disturbance
- Group fructose
- +2 more
- (no location specified)
Oct 5, 2022
Fatty Liver, Nonalcoholic, Liver Function Trial in Giza (low level laser, Mediterranean diet)
Completed
- Fatty Liver, Nonalcoholic
- Liver Function
- low level laser
- Mediterranean diet
-
Giza, Dokki, EgyptCairo
Sep 25, 2021
Liver Function Test Abnormalities in COVID-19
Completed
- Liver Function Tests Abnormalities
- No intervention
-
Sohag, EgyptMona Mohammed Abdelrhman
Sep 22, 2021
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Fatty Liver Trial in Naples
Completed
- Fatty Liver
-
Naples, ItalyUniversity of Campania Luigi Vanvitelli
Mar 27, 2023
Idiopathic Pulmonary Fibrosis Trial in Belfast (Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03), Placebo)
Completed
- Idiopathic Pulmonary Fibrosis
- Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03)
- Placebo
-
Belfast, United KingdomCelerion
Mar 4, 2022
Locally Advanced Head and Neck Squamous Cell Carcinoma Trial in New York (Cemiplimab, Cisplatin, Docetaxel)
Recruiting
- Locally Advanced Head and Neck Squamous Cell Carcinoma
- Cemiplimab
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Sep 6, 2022
Coxarthrosis Trial in Cluj-Napoca (direct anterior approach, direct lateral approach)
Completed
- Coxarthrosis
- direct anterior approach
- direct lateral approach
-
Cluj-Napoca, Cluj, RomaniaEmergency County Hospital Cluj-Napoca, Orthopedics and Trauma Cl
Feb 8, 2021